# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-053507
Filing Date
2024-04-29
Accepted
2024-04-29 08:05:54
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm2412214d2_ars.pdf | ARS | 923082
| Complete submission text file | 0001104659-24-053507.txt |  | 1272989

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36296 | Film No.: 24886681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)